優博訊(300531.SZ)終止設立產業基金並註銷杭州清科優博訊投資管理合夥企業(有限合夥)
格隆匯2月19日丨優博訊(300531.SZ)公佈,公司於2021年2月19日召開第三屆董事會第二十七次會議審議通過了《關於終止設立產業基金並註銷杭州清科優博訊投資管理合夥企業(有限合夥)的議案》,同意註銷合夥企業,並授權公司董事會辦理相關注銷事宜。
截至目前,合夥企業各方均未實際繳納出資,未實際開展相關業務,本次終止設立產業基金並註銷合夥企業不會對公司財務狀況和經營狀況產生影響,不存在損害公司及中小股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.